Eradicate cancer cells
escaping conventional treatment
SideROS aims to improve the conditions of patients affected by life-threatening diseases lacking of effective treatment.
SideROS promotes the development of innovative research on iron-targeting chemical compounds to target persistent cancer cells, refractory to conventional treatments and associated to metastasis and relapse.
Disturbing tumor cells metabolism, through specific inhibition of iron metabolism, is a novel targeted treatment
The role of iron is ubiquitous whatever the origin of cancer cells, suggesting that our small molecules can target various types of cancer.